Comparing the Performance Characteristics of Different Positive Expiratory Pressure Devices

References

1. 1.↵
   1. Knowles M,
   2. Boucher R

   . Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 2002;109(5):571–577.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Möller W,
   2. Häußinger K,
   3. Ziegler-Heitbrock L,
   4. Heyder J

   . Mucociliary and long-term particle clearance in airways of patients with immotile cilia. Respir Res 2006;7(1):10.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Hauber H,
   2. Foley S,
   3. Hamid Q

   . Mucin overproduction in chronic inflammatory lung disease. Can Respir J 2006;13(6):327–335.

   OpenUrlPubMed
4. 4.↵
   1. Miravitlles M,
   2. Calle M,
   3. Alvarez-Gutierrez F,
   4. Gobartt E,
   5. López F,
   6. Martín A

   . Exacerbations, hospital admissions and impaired health status in chronic obstructive pulmonary disease. Qual Life Res 2006;15(3):471–480.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.
   1. Corhay J,
   2. Vincken W,
   3. Schlesser M,
   4. Bossuyt P,
   5. Imschoot J

   . Chronic bronchitis in COPD patients is associated with increased risk of exacerbations: a cross-sectional multicentre study. Int J Clin Pract 2013;67(12):1294–1301.

   OpenUrl
6. 6.↵
   1. Burgel P,
   2. Nesme-Meyer P,
   3. Chanez P,
   4. Caillaud D,
   5. Carré P,
   6. Perez T,
   7. Roche N

   . Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest 2009;135(4):975–982.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Rabin HR,
   2. Butler SM,
   3. Wohl MB,
   4. Geller DE,
   5. Colin AA,
   6. Schidlow DV,
   7. et al

   . Pulmonary exacerbations in cystic fibrosis. Pediatr Pulmonol 2004;37(5):400–406.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Martínez-García M,
   2. Soler-Cataluna J,
   3. Perpiná-Tordera M,
   4. Román-Sánchez P,
   5. Soriano J

   . Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest 2007;132(5):1565–1572.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Loebinger M,
   2. Wells A,
   3. Hansell D,
   4. Chinyanganya N,
   5. Devaraj A,
   6. Meister M,
   7. Wilson R

   . Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J 2009;34(4):843–849.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Muñoz G,
    2. de Gracia J,
    3. Buxó M,
    4. Alvarez A,
    5. Vendrell M

    . Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial. Eur Respir J 2018;51(1):1701926.

    OpenUrlAbstract/FREE Full Text
11. 11.
    1. Figueiredo P,
    2. Zin W,
    3. Guimarães F

    . Flutter valve improves respiratory mechanics and sputum production in patients with bronchiectasis. Physiother Res Int 2012;17(1):12–20.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Tambascio J,
    2. de Souza L,
    3. Lisboa R,
    4. Rita de Cássia V,
    5. de Souza H,
    6. Gastaldi A

    . The influence of Flutter® VRP1 components on mucus transport of patients with bronchiectasis. Respir Med 2011;105(9):1316–1321.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Lee A,
    2. Burge A,
    3. Holland A

    . Airway clearance techniques for bronchiectasis. Cochrane Database Syst Rev 2015;(11):CD008351.
14. 14.↵
    1. Nicolini A,
    2. Mascardi V,
    3. Grecchi B,
    4. Ferrari-Bravo M,
    5. Banfi P,
    6. Barlascini C

    . Comparison of effectiveness of temporary positive expiratory pressure versus oscillatory positive expiratory pressure in severe COPD patients. Clin Respir J 2018;12(3):1274–1282.

    OpenUrl
15. 15.
    1. Farag TS,
    2. Mariam E-S

    . Utility of vest high frequency chest wall oscillation device versus flutter device in acute exacerbation of chronic obstructive pulmonary disease. Int J Res Med Sci 2017;6(1):1–9.

    OpenUrl
16. 16.↵
    1. Murray M,
    2. Pentland J,
    3. Hill A

    . A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis. Eur Respir J 2009;34(5):1086–1092.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Yang IA,
    2. Brown JL,
    3. George J,
    4. Jenkins S,
    5. McDonald CF,
    6. McDonald V,
    7. et al

    . The COPD-X Plan: Australian and New Zealand Guidelines for the Management of Chronic Obstructive Pulmonary Disease 2018, version 2.53. https://copdx.org.au/wp-content/uploads/2018/05/COPDX-V2-53-March-2018-1.pdf Accessed November 2, 2018.
18. 18.↵
    1. Osadnik C,
    2. McDonald C,
    3. Holland A

    . Advances in airway clearance technologies for chronic obstructive pulmonary disease. Expert Rev Respir Med 2013;7(6):673–685.

    OpenUrl
19. 19.↵
    1. Groth S,
    2. Stafanger G,
    3. Dirksen H,
    4. Andersen J,
    5. Falk M,
    6. Kelstrup M

    . Positive expiratory pressure (PEP-mask) physiotherapy improves ventilation and reduces volume of trapped gas in cystic fibrosis. Bull Eur Physiopathol Respir 1985;21(4):339–343.

    OpenUrlPubMedWeb of Science
20. 20.↵
    1. Oberwaldner B,
    2. Evans J,
    3. Zach M

    . Forced expirations against a variable resistance: a new chest physiotherapy method in cystic fibrosis. Pediatr Pulmonol 1986;2(6):358–367.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    1. Darbee J,
    2. Ohtake P,
    3. Grant B,
    4. Cerny F

    . Physiologic evidence for the efficacy of positive expiratory pressure as an airway clearance technique in patients with cystic fibrosis. Phys Ther 2004;84(6):524–537.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. McIlwaine P,
    2. Wong L,
    3. Peacock D,
    4. Davidson A

    . Long-term comparative trial of positive expiratory pressure versus oscillating positive expiratory pressure (flutter) physiotherapy in the treatment of cystic fibrosis. J Pediatr 2001;138(6):845–850.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.
    1. Myers T

    . Positive expiratory pressure and oscillatory positive expiratory pressure therapies. Respir Care 2007;52(10):1308–1327.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Lee A,
    2. Burge A,
    3. Holland A

    . Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis. Cochrane Database Syst Rev 2015;(5):CD011699.
25. 25.↵
    1. Andersen J,
    2. Qvist J,
    3. Kann T

    . Recruiting collapsed lung through collateral channels with positive end-expiratory pressure. Scand J Respir Dis 1979;60(5):260–266.

    OpenUrlPubMedWeb of Science
26. 26.↵
    1. App E,
    2. Kieselmann R,
    3. Reinhardt D,
    4. Lindemann H,
    5. Dasgupta B,
    6. King M,
    7. Brand P

    . Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy: flutter vs autogenic drainage. Chest 1998;114(1):171–177.

    OpenUrlCrossRefPubMedWeb of Science
27. 27.↵
    1. Lee A,
    2. Williamson H,
    3. Lorensini S,
    4. Spencer L

    . The effects of oscillating positive expiratory pressure therapy in adults with stable non-cystic fibrosis bronchiectasis: a systematic review. Chron Respir Dis 2015;12(1):36–46.

    OpenUrlCrossRefPubMed
28. 28.↵
    1. Alves L,
    2. Pitta F,
    3. Brunetto A

    . Performance analysis of the Flutter VRP1 under different flows and angles. Respir Care 2008;53(3):316–323.

    OpenUrlAbstract/FREE Full Text
29. 29.↵
    1. Mueller G,
    2. Bersch-Porada I,
    3. Koch-Borner S,
    4. Raab A,
    5. Jonker M,
    6. Baumberger M,
    7. Michel F

    . Laboratory evaluation of four different devices for secretion mobilization: Acapella Choice, Green and Blue versus water bottle. Respir Care 2014;59(5):673–677.

    OpenUrlAbstract/FREE Full Text
30. 30.↵
    1. Chilvers M,
    2. Rutman A,
    3. O'Callaghan C

    . Functional analysis of cilia and ciliated epithelial ultrastructure in healthy children and young adults. Thorax 2003;58(4):333–338.

    OpenUrlAbstract/FREE Full Text
31. 31.
    1. Yager J,
    2. Ellman H,
    3. Dulfano M

    . Human ciliary beat frequency at three levels of the tracheobronchial tree. Am Rev Respir Dis 1980;121(4):661–665.

    OpenUrlPubMedWeb of Science
32. 32.
    1. Zhang L,
    2. Han D,
    3. Wang H,
    4. Zhou B,
    5. Sanderson M

    . Measurement of respiratory ciliary beat frequency quantified with high-speed digital microscopy. Zhonghua Er Bi Yan Hou Ke Za Zhi 2004;39(7):433–437.

    OpenUrlPubMed
33. 33.↵
    1. Patterson J,
    2. Hewitt O,
    3. Kent L,
    4. Bradbury I,
    5. Elborn J,
    6. Bradley J

    . Acapella® versus usual airway clearance during acute exacerbation in bronchiectasis: a randomized crossover trial. Chron Respir Dis 2007;4(2):67–74.

    OpenUrlCrossRefPubMed
34. 34.
    1. Cegla U,
    2. Retzow A

    . Physical therapy with VRP1 in chronic obstructive respiratory tract diseases-results of a multicenter comparative study. Pneumologie 1993;47(11):636–639.

    OpenUrlPubMed
35. 35.↵
    1. de Lima L,
    2. Duarte J,
    3. Lepore Neto F,
    4. Abe P,
    5. Gastaldi A

    . Mechanical evaluation of a respiratory device. Med Eng Phys 2005;27:181–187.

    OpenUrlPubMed
36. 36.↵
    1. King M,
    2. Phillips D,
    3. Gross D,
    4. Vartian V,
    5. Chang H,
    6. Zidulka A

    . Enhanced tracehal mucus clearance with high frequency chest wall compression. Am Rev Respir Dis 1983;128(3):511–515.

    OpenUrlPubMedWeb of Science
37. 37.↵
    1. Chang A,
    2. Bell S,
    3. Torzillo P,
    4. King P,
    5. Maguire G,
    6. Byrnes C,
    7. et al

    . Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines. Med J Aust 2015;202(3):130.

    OpenUrl
38. 38.
    1. Button B,
    2. Wilson C,
    3. Dentice R,
    4. Cox N,
    5. Middleton A,
    6. Tannenbaum E,
    7. et al

    . Physiotherapy for cystic fibrosis in Australia and New Zealand: a clinical practice guideline. Respirology 2016;21(4):656–667.

    OpenUrl
39. 39.
    NICE clinical guidelines: Obstructive pulmonary disease in over 16s: diagnosis and management 2010:CG101.
40. 40.
    1. Pasteur M,
    2. Bilton D,
    3. Hill A

    . British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010;65(1):1–58.

    OpenUrlFREE Full Text
41. 41.↵
    1. Polverino E,
    2. Goeminne P,
    3. McDonnell M,
    4. Aliberti S,
    5. Marshall S,
    6. Loebinger M,
    7. et al

    . European respiratory society guidelines for the management of adult bronchiectasis. Eur Respir J 2017;50(3):1700629.

    OpenUrlAbstract/FREE Full Text
42. 42.↵
    1. Elkins M,
    2. Jones A,
    3. van der Schans C

    . Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis. Cochrane Database Syst Rev 2004;1:CD003147.

    OpenUrl
43. 43.↵
    1. McIlwaine P,
    2. Button B,
    3. Dwan K

    . Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis. Cochrane Database Syst Rev 2015;1:CD003147.

    OpenUrl
44. 44.↵
    1. Van Fleet H,
    2. Dunn D,
    3. McNinch N,
    4. Volsko T

    . Evaluation of functional characteristics of 4 oscillatory positive pressure devices in a simulated cystic fibrosis model. Respir Care 2017;62(4):451–458.

    OpenUrlAbstract/FREE Full Text
45. 45.↵
    1. Berlinski A

    . In-vitro evaluation of positive expiratory pressure devices attached to nebulizers. Respir Care 2014;59(2):216–222.

    OpenUrlAbstract/FREE Full Text
46. 46.↵
    1. Rand S,
    2. Aurora P,
    3. Main E

    . PEP therapy in secretion management. Hosp Healthc Eur 2015:113–116.
47. 47.↵
    1. Volsko T,
    2. DiFiore J,
    3. Chatburn R

    . Performance comparison of two oscillating positive expiratory pressure devices: Acapella versus Flutter. Respir Care 2003;48(2):124–130.

    OpenUrlAbstract/FREE Full Text
48. 48.↵
    1. Patterson J,
    2. Bradley J,
    3. Hewitt O,
    4. Bradbury I,
    5. Elborn J

    . Airway clearance in bronchiectasis: a randomized crossover trial of active cycle of breathing techniques versus Acapella®. Respiration 2005;72(3):239–242.

    OpenUrlCrossRefPubMedWeb of Science
49. 49.↵
    1. Svenningsen S,
    2. Paulin G,
    3. Sheikh K,
    4. Guo F,
    5. Hasany A,
    6. Kirby M,
    7. et al

    . Oscillatory positive expiratory pressure in chronic obstructive pulmonary disease. COPD 2016;13(1):66–74.

    OpenUrl
50. 50.↵
    1. dos Santos A,
    2. Guimaraes R,
    3. de Carvalho E,
    4. Gastaldi A

    . Mechanical behaviours of Flutter VRP1, Shaker and Acapella Devices Respir Care 2013;58(2):298–304.

    OpenUrlAbstract/FREE Full Text
51. 51.↵
    1. Lindemann H

    . The value of physical therapy with VRP 1-Desitin (“Flutter”). Pneumologie 1992;46:626–630.

    OpenUrlPubMed
52. 52.↵
    1. Alves Silva CE,
    2. Santos J,
    3. Jansen J,
    4. de Melo P

    . Laboratory evaluation of the Acapella device: pressure characteristics under different conditions, and a software tool to optimize its practical use. Respir Care 2009;54(11):1480–1487.

    OpenUrlAbstract/FREE Full Text
53. 53.↵
    1. Brooks D,
    2. Newbold E,
    3. Kozar L,
    4. Rivera M

    . The flutter device and expiratory pressures. J Cardiopulm Rehabil Prev 2002;22(1):53–57.

    OpenUrl
54. 54.↵
    1. Alves C,
    2. Nunes L,
    3. Melo P

    . Mechanical analysis of an oscillatory positive expiratory pressure device used in respiratory rehabilitation. Conf Proc IEEE Eng Med Biol Soc 2010;2477–2480.
55. 55.↵
    1. Suggett J,
    2. Meyer A,
    3. Costella S,
    4. Morton R,
    5. Mitchell J

    . Assessment of oscillating positive expiratory pressure (OPEP) devices by means of adult expiratory waveforms: a laboratory study. Am J Respir Crit Care Med 2014;189:A3036.

    OpenUrl
56. 56.↵
    1. Pursley D

    . Analysis of three oscillating positive expiratory pressure devices during simulated breathing. Respir Ther 2017;12(1):52–56.

    OpenUrl
57. 57.↵
    1. Falk M,
    2. Kelstrup M,
    3. Andersen J,
    4. Kinoshita T,
    5. Falk P,
    6. Støvring S,
    7. Gothen I

    . Improving the ketchup bottle method with positive expiratory pressure, PEP, in cystic fibrosis Eur J Respir Dis 1984;65(6):423–432.

    OpenUrlPubMedWeb of Science
58. 58.↵
    1. McIlwaine M,
    2. Bradley J,
    3. Elborn J,
    4. Moran F

    . Personalising airway clearance in chronic lung disease. Eur Resp Rev 2017;26(143):160086.

    OpenUrl
59. 59.↵
    1. Freitag L,
    2. Kim C,
    3. Long W,
    4. Venegas J,
    5. Wanner A

    . Mobilization of mucus by airway oscillations. Acta Anaesthesiol Scand 1989;33(90):93–101.

    OpenUrlPubMedWeb of Science